ANMDMR - Nomenclatorul medicamentelor pentru uz uman
Actualizat în 09.10.2024
  Anulare filtru   Descarcă Varianta Excel
Denumire comercială  DCI  Forma farmaceutică  Cod ATC  Cod CIM  Firma / țara deținătoare APP 
TAVANIC 500 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W55700001 TERAPIA S.A. - ROMANIA
TAVANIC 500 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W55700002 TERAPIA S.A. - ROMANIA
TAVANIC 500 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W55700003 TERAPIA S.A. - ROMANIA
TAVIPEC 150 mg PLANTE (LAVANDA) CAPS. MOI GASTROREZ. R07AXN2 W43190001 PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H. - AUSTRIA
TAVIPEC 150 mg PLANTE (LAVANDA) CAPS. MOI GASTROREZ. R07AXN2 W43190002 PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H. - AUSTRIA
TAVIPEC FORTE 300 mg PLANTE (LAVANDA) CAPS. MOI GASTROREZ. R05CB W70082001 PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H. - AUSTRIA
TAVIPEC FORTE 300 mg PLANTE (LAVANDA) CAPS. MOI GASTROREZ. R05CB W70082002 PHARMAZEUTISCHE FABRIK MONTAVIT GES.M.B.H. - AUSTRIA
TAVNEOS 10 mg AVACOPANUM CAPS. TARI L04AJ05 W69951001 VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE - FRANTA X
TAVNEOS 10 mg AVACOPANUM CAPS. TARI L04AJ05 W69951002 VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE - FRANTA X
TAVNEOS 10 mg AVACOPANUM CAPS. TARI L04AJ05 W69951003 VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA FRANCE - FRANTA X
TAVOFLOX 250 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W69894001 TERAPIA S.A. - ROMANIA
TAVOFLOX 250 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W69894002 TERAPIA S.A. - ROMANIA
TAVOFLOX 250 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W69894003 TERAPIA S.A. - ROMANIA
TAVOFLOX 500 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W69895001 TERAPIA S.A. - ROMANIA
TAVOFLOX 500 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W69895002 TERAPIA S.A. - ROMANIA
TAVOFLOX 500 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W69895003 TERAPIA S.A. - ROMANIA
TAVOFLOX 500 mg LEVOFLOXACINUM COMPR. FILM. J01MA12 W69895004 TERAPIA S.A. - ROMANIA
TECARTUS 0,4 - 2 × 10{8} celule dispersie perfuzabila BREXUCABTAGENUM AUTOLEUCELUM CELULE DISPERSIE PERFUZABILA L01XL06 W70447001 KITE PHARMA EU B.V. - OLANDA X
TECENTRIQ 1200 mg ATEZOLIZUMAB CONC. PT. SOL. PERF. L01FF05 W64295001 ROCHE REGISTRATION GMBH - GERMANIA X
TECENTRIQ 1875 mg ATEZOLIZUMAB SOL. INJ.  L01FF05 W69966001 ROCHE REGISTRATION GMBH - GERMANIA X